HPE
34
17
SLG
44
2
AMP
60
-6
K
59
3
FIS
75
3
JWN
60
3
EBAY
49
5
MKC
68
6
HCA
57
2
SCHW
67
2
EA
65
5
AKAM
42
7
MCD
59
2
EQR
47
2
EMR
60
4
BAC
65
2
PEP
56
5
M
33
8
RF
50
3
EQIX
47
2
HPE
34
17
SLG
44
2
AMP
60
-6
K
59
3
FIS
75
3
JWN
60
3
EBAY
49
5
MKC
68
6
HCA
57
2
SCHW
67
2
EA
65
5
AKAM
42
7
MCD
59
2
EQR
47
2
EMR
60
4
BAC
65
2
PEP
56
5
M
33
8
RF
50
3
EQIX
47
2
Financhill
Back

Bicycle Therapeutics PLC 10K Form

Sell
12

BCYC
Bicycle Therapeutics PLC

Last Price:
$9.55
Seasonality Move:
-7.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-11-05 10Q BCYC/Bicycle Therapeutics PLC Quarterly
2020-08-05 10Q BCYC/Bicycle Therapeutics PLC Quarterly
2020-05-07 10Q BCYC/Bicycle Therapeutics PLC Quarterly
2020-03-10 10K BCYC/Bicycle Therapeutics PLC Annual
2019-11-07 10Q BCYC/Bicycle Therapeutics PLC Quarterly
2019-08-08 10Q BCYC/Bicycle Therapeutics PLC Quarterly

Receive BCYC News And Ratings

See the #1 stock for the next 7 days that we like better than BCYC

BCYC Financial Statistics

Sales & Book Value

Annual Sales: $35.3M
Cash Flow: $-9.8M
Price / Cash Flow: 0
Annual Sales: $11.48
Price / Book: 0.87

Profitability

EPS (TTM): -2.88000
Net Income (TTM): $-169M
Gross Margin: --
Return on Equity: -26.21%
Return on Assets: -20.35%

Bicycle Therapeutics PLC Earnings Forecast

Key Bicycle Therapeutics PLC Financial Ratios

  • The Research & Development expenses have been 490.34% of Revenue.
  • The Net Earning history of BCYC is -479.18% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Bicycle Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BCYC
CUSIP: 088786
Website: bicycletherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 13.81
Quick Ratio: 13.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BCYC Technical Analysis vs Fundamental Analysis

Sell
12
Bicycle Therapeutics PLC (BCYC) is a Sell

Is Bicycle Therapeutics PLC a Buy or a Sell?